Schonfeld Strategic Advisors LLC Aptorum Group LTD Transaction History

Schonfeld Strategic Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.14 - $12.9 $227 - $2,580	200 Added 0.45%	45,000 $52,000
Q2 2022 Aug 15, 2022	BUY	$0.95 - $1.67 $285 - $501	300 Added 0.67%	44,800 $62,000
Q1 2022 May 16, 2022	BUY	$1.22 - $2.28 $488 - $911	400 Added 0.91%	44,500 $75,000
Q4 2021 Feb 14, 2022	SELL	$1.5 - $2.64 $150 - $264	-100 Reduced 0.23%	44,100 $66,000
Q3 2021 Nov 16, 2021	BUY	$2.39 - $3.22 $956 - $1,288	400 Added 0.91%	44,200 $114,000
Q1 2021 May 17, 2021	SELL	$2.45 - $4.17 $3,185 - $5,421	-1,300 Reduced 2.88%	43,800 $131,000
Q4 2020 Feb 16, 2021	BUY	$2.03 - $2.89 $91,552 - $130,339	45,100 New	45,100 $112,000

Ticker APM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,265,500
Market Cap $28.1M
Description
Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.